compared with local effects at spinal opioid receptors and it remains unclear whether epidural administration has advantages over the i.v. route in providing better analgesia and/or improved side-effect profile.
Thus, the objective of the current study was to investigate methadone disposition and antinociceptive effect after i.v. and epidural administration in a rat model of thermal nociception.
Methods

Animals and surgery
All surgical and experimental procedures were approved by the Animal Experimentation Ethics Committee of The Hebrew University Hadassah Medical School, Jerusalem. Male SpragueDawley rats (Harlan, Israel) were used. Before surgery, rats were kept at 12-h light/dark cycle with ad libitum access to food and water. On each of 2 days before surgery, the rats were habituated for handling and thermal nociception testing. Surgical anaesthesia consisted of 1 ml kg 21 of ketamine 20 mg ml 21 (Fort Dodge, IA, USA): xylazine 100 mg ml 21 (90:10 v/v) by intra-peritoneal injection, maintained by pure ketamine as needed.
A catheter of polyethylene tubing (PE50, Intramedic w , Becton Dickinson, MD, USA) was placed in the right jugular vein of all rats to allow drug administration and blood sampling. An epidural catheter was placed in half of the animals in the same anaesthesia session. 17 Briefly, the dorsal thoracolumbar spinal region was clipped and sterilized with isopropanol. A 1-2 cm midline skin incision was made caudal to the T13 spinous process. Muscles were bluntly dissected from the vertebrae and retracted to expose the L1 -L2 intervertebral space. The intervertebral ligament was carefully cut and an epidural catheter [a 14 cm polyethylene tube (PE-10; Braintree Scientific, Braintree, MA, USA)] was inserted into the epidural space 1.5 cm caudally. To reduce the possibility of catheter migration, two knots were tied on the catheter with 1 cm of PE-50 tubing, and on top of it, with 3 mm wide Silastic w tubing (Dow Corning, Midland, MI, USA). The first knot was made 2.0 cm from the caudal catheter tip, and was sutured to the paravertebral muscles between the L1 and L2 vertebrae. The second knot was made 9.0 cm distal to the first knot and was sutured at the dorsal neck catheter exteriorization site. The dead space in the catheter was 8+1 ml. No hole or groove in the bone was made and no bone was dissected. The catheter tip was located at the L3-L4 level. Fluid-free aspiration ensured that the catheter placement was not intrathecal or intravascular. The catheter was flushed with 20 ml of sterile saline and plugged with a 28G steel wire. The muscles and fascia were sutured, and then the skin was closed using stainless steel wound clips. Both i.v. and epidural catheters were tunnelled subcutaneously and were exteriorized at the dorsal. After the surgery, animals were transferred to individual cages with ad libitum access to food and water to recover for 24 h. Eight and 24 h after epidural catheter placement surgery, animals were evaluated for sensory and motor function of the hind limbs, and thermal latencies of the tail. Only rats with no motor or sensory disturbance on the first postoperative day (compared with preoperative values) were used. 
Assessment of nociceptive response
The effect of methadone after administration by each route was investigated using two thermal nociception methods: hot water tail immersion test (by immersing the distal 2 cm of the tail in 498C water) and by tail-flick test (Tail Flick Analgesia Monitor, Accuscan Instruments, OH, USA). With both methods, the time to tail-withdrawal (in seconds) was assessed as a measure of nociception. In order to control for inter-animal differences in thermal nociception models, 20 antinociception was expressed as the per cent of maximal possible effect (%MPE) over time, calculated for each dose and time point. %MPE = measured latency − baseline latency cutoff latency − baseline latency × 100% (1)
Comparison of epidural and i.v. methadone
Latency was determined from an average of three measurements. To minimize the possibility of thermal injury, the cut-off latency for hot water immersion was 20 s and the cut-off latency for tail-flick was 15 s.
Supraspinal effects
Pinna reflex (by alternatively touching the auditory meatus to elicit a head shake) and corneal reflex (by light alternative touching of both corneas with a blunt paper instrument to elicit an eye blink) were assessed at 3, 6, and 9 min after methadone administration. The absence of the reflexes was indicative of undesired opioid supraspinal effects. 21 -23 Methadone analysis
Determination of methadone plasma concentration was performed using a Waters Millennium HPLC-MS equipped with Micromass ZQ detector, Waters 600 Controller gradient pump, Waters 717 auto-sampler, and Xterra w MS C8 column (3.5 mm, 2.1×100 mm, Waters, Ireland). The mobile phase consisted of methanol -water (35:65) containing 0.1% (v/v) formic acid, and the flow was 0.3 ml min 21 . Solvents were purchased from J.T. Baker, USA. Nitrogen flow was 500 litre h 21 , source temperature was 4008C, the cone voltage was 12 V. Retention times for methadone and internal standard midazolam (Sigma, St Louis, MO, USA) were 7.2 and 3.1 min. The quantification range for methadone was 5-500 ng ml 21 .
Pharmacokinetic and pharmacodynamic data analysis
The concentration-time data for methadone after i.v. and epidural administration were analysed by a non-compartmental approach. Terminal half-life, area under the concentrationtime curve from time zero to infinity (AUC, calculated by linear trapezoidal method), mean residence time (MRT), volume of distribution at steady state (Vss), and clearance (Cl) were calculated for individual concentration-time profiles. To obtain a measure for cumulative antinociceptive effect over time (for both tests), area under the effect vs time curve (AUEC) for each animal was calculated using the trapezoidal rule (without extrapolation to infinite time). 24 To further investigate pharmacokinetic -pharmacodynamic (PK -PD) relationships, a model-based approach was utilized. Initially, the PK model describing the disposition and elimination of methadone after i.v. administration was established; then, the model was extended to describe the tail-flick antinociceptive effect for i.v. administration. As the PK profiles after epidural administration were not significantly different from those obtained after i.v. injection (see Results), a separate PK model for epidural data was not developed. The PD model for epidural methadone included two sites of action. Finally, i.v. concentration-time data (three dose levels) were co-modelled with tailflick data after both i.v. and epidural routes of administration (four dose levels), and all model parameters were estimated simultaneously. The following equations were used to describe the final model:
where C p represents methadone concentration at the central distribution compartment, A t is the amount of the drug at the peripheral compartment, and k pt and k tp are the corresponding first-order distribution rate constants. The drug is eliminated through a saturable elimination pathway (V max and K m ). The effect after i.v. administration (E IV ) is proportional to concentration in the central compartment. Total drug effect after epidural administration (E total epi ) is composed of the effect achieved due to systemic uptake (1) and the effect achieved at the spinal level (E max and EC 50 ). Model fitting and parameter estimation were performed using MATLAB R2009a (The MathWorks, Natick, MA, USA).
Statistics
Comparisons between cumulative antinociceptive effects and areas under concentration -time curve (AUCs) of i.v. vs epidural methadone in same dose groups were carried out using Student's t-test. Intergroup PD differences among different doses of same route of methadone administration were tested using one-way analysis of variance (ANOVA), with pairwise multiple comparison procedures performed using the HolmSidak method. The comparison between binary outcome of maximum antinociceptive effect at 1 between epidural and i.v. methadone administration was performed using Fisher's exact test. Plasma concentrations of epidural vs i.v. methadone at each time point (per dose) were compared by Student's test with Bonferroni correction for multiple comparisons. Statistical analysis was performed using Sigma Plot 11.0 (Systat Software, Inc., San Jose, CA, USA), with differences being considered significant at P≤0.05.
Results
Animals
The mean (SD) weight of the animals before surgery was 309 (37) g, and 24 h after surgery was 290 (35) g (n¼56). Three animals did not return to baseline sensory and motor function of the hind limbs 8 h after surgery. The epidural catheter was found in the subcutaneous tissue in three animals and in the intrathecal space in four animals. Data from 46 animals were included in the analysis. Baseline tail flick and hot water tail immersion latencies were not different before and 24 h after catheter placement.
Methadone pharmacokinetics
Mean serum concentration-time profiles of methadone after i.v. 
Methadone pharmacodynamics
Mean (SD) baseline tail-flick and hot water tail immersion test latencies were 7.1 (1.0) and 9.2 (2.2) s, immediately before administration of the drug. In control groups, administration of normal saline via the epidural (n¼4) or i.v. (n¼4) catheter did not change baseline latency values for either test over the 180 min period. Methadone pharmacodynamics showed high intragroup variability. In both epidural and i.v. groups, the onset of antinociception was fast and the maximal effect was observed at the first measurement (in a majority of animals). The antinociceptive effect after epidural administration was stronger than with i.v. administration, except for the lowest dose of 0.1 mg kg 21 , at which the effect was very mild. Mean %MPE data vs time for the tail-flick test for both routes of administration and four doses is shown in Figure 2 . Experimental data were reasonably captured by the proposed model structure (Fig. 2 ) and parameters were estimated with good precision ( Table 2 ). The corresponding values for AUEC (used as a measure of cumulative antinociceptive effect) are shown in Figure 4A . Mean %MPE data vs time for hot water tail immersion test for both routes of administration and four doses are shown in Figure 3 , and the corresponding values for AUEC are shown in Figure 4B .
The duration of antinociceptive effect was longer with epidural administration of methadone. Sixty minutes after methadone administration, the percentage of rats having maximum antinociceptive effect (100% MPE) was higher after epidural administration of 0.5 mg kg 21 (50% vs 0% of animals, P¼0.05), and 0.75 mg kg 21 (83% vs 0% of animals,
P¼0.015).
Methadone supraspinal effects
Corneal reflex was temporarily absent only at 0.75 mg kg reflex was present at all time-points in all dose groups (Table 3) .
Discussion
The results demonstrate an advantage of epidural compared with i.v. administration of methadone in terms of improved antinociceptive efficacy and reduced undesired supraspinal opioid effects in this model. The plasma concentration profiles of methadone obtained after epidural administration were not different from those of i.v. administration. Similar findings have previously been reported for other lipophilic opioids. 25 The epidural space is rich in blood vessels, and methadone might undergo rapid absorption and distribution to the systemic circulation. The doseresponse curves obtained with each of the thermal nociception models show separation of the PD effect at doses ≥0.25 mg kg 21 , suggesting that antinociception after epidural administration of methadone is beyond that contributed by its systemic effect.
The magnitude and duration of the analgesic and toxic effects of epidural opioids are difficult to predict based solely on physicochemical properties. 26 While lipophilicity and ionization usually predict a molecule's ability to cross biological membranes, these parameters, together with molecular mass, volume, and surface area, are not linearly correlated to meningeal permeability. 27 28 The spinal effect of epidural opioids is mediated by local administration at the proximity to the spinal cord, and by the supraspinal effects achieved by distribution to the brainstem and brain by cephalad CSF spread and systemic circulation. Many opioids including morphine, hydromorphone, fentanyl and alfentanil appear in the cerebello-medullary system after lumbar epidural or intrathecal administration. With epidural methadone, on the contrary, cephalad spread is unlikely, as methadone is not detectable in the CSF at cervical or intracerebroventricular levels after lumbar intrathecal or epidural administration. 10 11 29 Systemic administration of opioids result mainly in supraspinal sites of action, but local action at the spinal site after neuraxial administration is sufficient to provide complete antinociception. 30 31 Independent spinal and supraspinal administration of opioids provide synergistic antinociceptive effect 30 -32 ; considering negligible rostral spread of methadone after lumbar epidural administration, 10 11 29 the supraspinal effect achieved from systemic methadone distribution after epidural injection could potentiate the local spinal effect and result in the enhanced antinociception we observed with the epidural administration. Despite similar PK profile, we observed reduced supraspinal effects with epidural methadone which provides further indirect evidence for the lack of cephalad spread. This finding was consistently observed at doses above 0.1 mg kg 21 . Similar findings of differences in corneal and pinna reflexes were reported for i.v. and epidural sufentanil. 25 We suggest that i.v. bolus administration of lipophilic methadone, especially into the jugular vein, produces a peak brain concentration, higher than after epidural administration despite similar plasma concentration measured 2 min after injection. This is supported by 50% higher plasma concentration of methadone measured at 1 min compared with 2 min after i.v. injection in rats. 33 An absorption phase from the epidural space to the systemic circulation might have caused lower initial plasma and, therefore, brain concentrations of methadone during the first 2 min after the injection, leading to less supraspinal effect. The absorption phase might also explain the finding of higher plasma concentration of methadone 2 min after the epidural 0.5 mg kg 21 dose, which might have coincided with the peak plasma concentration. However, this hypothesis will require further investigation with more frequent initial blood sampling. A PK-PD modelling approach was used to further evaluate the experimental findings. Initially, the PK model included a separate epidural compartment, but due to a very fast absorption and lack of the absorption phase in the PK profiles, the absorption rate constant could not be estimated. To describe the Potential limitations of our study include our inability to perform a priori sample size calculation to determine the optimal group size to detect differences in plasma concentrations between the two routes of administration, since no pharmacokinetic data on epidural methadone were available in rats. In addition, our blood sampling schedule did not capture the PK profile of methadone in the first 2 min after administration, which potentially could be different between the two administration routes due to a rapid redistribution phase after i.v. and absorption phase after epidural administration.
Few studies have investigated epidural methadone clinically. Prieto-Alvarez and colleagues reported effective postoperative analgesia with epidural methadone, without accumulation in plasma for 72 h after operation in abdominal and lower-limb surgery. 15 Shir and colleagues also demonstrated good postoperative pain relief, but reported increasing plasma concentrations after continuous epidural methadone administration, reaching those obtained with systemic dosing. 16 Epidural methadone was as effective as epidural fentanyl after abdominal surgery 14 and superior to epidural morphine for Caesarean section in terms of analgesia 12 or urinary retention and need for bladder catheterization. 13 Based on currently available clinical trials, it is difficult to draw conclusions on the clinical utility of epidural methadone. It is especially challenging to compare its efficacy and safety to other opioids, because studies have utilized different dose regimens of epidural methadone, and some of the differences might be accounted for by the use of non-equianalgesic dose ratios.
Methadone by the epidural route is not approved by most regulatory agencies, including the US FDA. Its clinical use is limited, and despite a few studies reporting long-term use of neuraxial methadone, 40 41 initial data in dogs suggest that methadone, like other NMDA antagonists, can cause spinal cord pathology after long-term intrathecal infusion. 42 More formal safety data on epidural methadone might be required before further clinical studies are performed. 43 The findings of comparable plasma concentrations and the advantage in antinociceptive and supraspinal effect profiles of epidural methadone in this study, combined with its physicochemical properties and evidence supporting the lack of cephalad spread in the CSF after epidural administration, make methadone a particularly interesting molecule warranting further preclinical and clinical investigation in the setting of postoperative epidural analgesia.
